Introduction
Antibiotic resistance is a rapidly growing healthcare problem globally, and has been recognized by the WHO as one of the greatest threats to the fundamental achievements of medicine. 1 A key component for understanding the risks of resistance development is the ability to detect and quantify antibiotic resistance in various settings-the so-called resistome-including bacterial communities dwelling in and on our bodies. This can, for example, aid in understanding the transmission of resistance in the hospital environment. Furthermore, there is substantial evidence that a large portion of the resistance genes circulating among human pathogens today originate from bacteria that thrive in the external environment. [2] [3] [4] Contaminated water and food also serve as transmission routes for many bacterial pathogens, particularly faecal bacteria. Moreover, the consequences of antibiotic use in animals have become a great concern for human health as well. 5 Hence, a 'one-health' approach including human, animal and environmental aspects of the resistance problem is needed. 6, 7 This, in turn, makes it important to also understand risks associated with resistance genes encountered in different external environments, including in animals. [8] [9] [10] This paper gives an overview of approaches to the study of resistomes using high-throughput DNA sequencing and outlines some pitfalls that can influence the evaluation of risks associated with resistance gene findings.
Studying the resistome
Resistance patterns among bacteria have traditionally been studied using culture on media selecting for resistant bacteria.
However, when we move away from the most well-studied pathogens, the vast majority of microorganisms cannot be cultured, at least not by standard methods. 11 This limits the possible scope of this method and thereby veils much of the diversity of species and resistance factors, particularly in environmental communities. For this reason, culture-independent methods to study resistance genes have been developed, enhanced by rapidly declining costs of DNA sequencing throughout the last decade. A common approach is to randomly fragment the total DNA of a complete community and sequence it by high-throughput sequencing, a procedure referred to as shotgun metagenomics. 12 The resulting DNA fragments can be analysed using similarity searches against sequence databases, or assembled into longer stretches of DNA, allowing the reconstruction of complete genes from the relatively short-read fragments. However, shotgun metagenomics still requires that the obtained genes, or close variants of them, are present in a reference database to enable their assignment to a (predicted) resistance phenotype. That said, since sequence data can be stored and re-used later, shotgun metagenomics allows the retrospective analysis of resistance genes identified after the initial study has been completed. 13, 14 Shotgun metagenomics has been applied to quantify the abundances of many resistance genes in parallel, for example in environments subjected to pharmaceutical pollution, 15, 16 sewage treatment plants, [17] [18] [19] sea water, 20 tap water 21 and the human gut. 13, 22 However, in terms of measuring specific gene abundances, metagenomics is less sensitive (i.e. has higher detection limits) than quantitative real-time PCR (qPCR), particularly when only a few million reads are generated per sample. In this respect, Illumina sequencing was a major step forward compared with massively parallel pyrosequencing, simply due to the lower costs associated with each read. Limited sequencing depth affects the ability to estimate both the abundances and the diversity of resistance genes in the sample, which will be discussed in a later section of this paper.
Thousands of antibiotic resistance gene variants are known. A major advantage of shotgun metagenomics compared with qPCR is the ability to investigate all of these variants-including variants not detected by the PCR primers-in a single experiment. Moreover, using the same data, it is also possible to detect changes in taxonomic composition and other functional genes, for example those involved in horizontal gene transfer. This can provide clues about whether the resistance genes detected have the potential to move between bacterial cells or not. Furthermore, through metagenomic assembly it is sometimes possible to uncover co-resistance patterns, or even completely novel resistance plasmids. 15, 19 Obtaining sequence data from microbial communities
As a first step in any metagenomics analysis, DNA must be extracted from the microbial community. This is usually done using standard DNA extraction kits. However, as most microbial communities comprise a large diversity of different bacteria and also may contain contaminants of different kinds, this process is not always straightforward. It is important to understand that extraction protocols can bias gene frequencies, as not all bacterial species are affected equally by the reagents used. Bias has been shown to result from differences between DNA extraction kits, 23, 24 storage of samples 24, 25 and DNA amplification kits, 26 as well as biological variation of, for example, GC content. 27 All these factors contribute noise to the samples even before the sequencing takes place. 28 However, different sequencing techniques also produce different results, partially because of differences in sequence length for each fragment, but also due to the different methodologies used to determine the nucleotide sequences. 29 Before any other analyses are performed, it is advisable to filter the sequence data with respect to sequencing adapters and low-quality reads. 30 Since paired-end sequencing is becoming the norm, filtering software that can consider both reads in a pair simultaneously is desirable. This can be done using a variety of software, for example Trim Galore!, 31 Trimmomatic, 32 Sickle 33 or Prinseq.
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Detecting and quantifying resistance genes in metagenomes
Gaining insights into the resistance gene content of a microbial community from sequence data requires the ability to detect resistance genes among sequence fragments derived from a multitude of different genes. This is achieved through similarity searches, employing the principle that genes sharing homology often perform similar functions. This principle is at the heart of bioinformatic methods, but, depending on the questions asked, its usefulness differs. Often, changes of only a few amino acid residues in a protein can alter its substrate preferences, 35, 36 binding sites 37, 38 or overall functions. 39, 40 Therefore, the validity of the assumption that a read matching a protein in a reference database comes from a gene encoding a protein with the same function is dependent on how similar the read is to the reference sequence. 41 This means that the choice of method for assigning function to metagenomic reads depends on which stringency one aims for. In the case of mobilized genes, their sequences show limited variation once they have appeared on mobile genetic elements (MGEs). 42 Because of the inherent dependency on sequence similarity, selecting an appropriate sequence identity cut-off for calling a matching read a resistance gene becomes crucial. 8 At the same time, reads come with a certain degree of sequencing errors, and there might be slight differences between resistance genes that do have the same function. Therefore, one wants to allow for a certain degree of mismatch between the read and the reference sequence-the question is: how large can this difference be if stringency is to be maintained? The answer to this question depends on how similar the resistance genes known to carry out the same function are. However, the percentage identity of functionally verified resistance genes within the same group varies substantially ( Figure 1 ). In Resqu 43 (a database containing only resistance genes with experimentally verified function), the average sequence identity between sequences associated with the same gene name and function differs between 68% and completely identical (median 97.9%), while the median lowest identity between two sequences with the same gene name is 95.3%, but can be as low as 52.8% (the vanSG vancomycin resistance gene). However, applying a universal cut-off of 50% sequence identity would produce an immense number of false-positive hits. Using the IMP b-lactamase as an example, performing a BLAST search 44 against the NCBI protein database 45 with the IMP sequences as queries yields .200 matches at a 50% identity cut-off (requiring 30 matching amino acids, corresponding to the length of a typical Illumina read). These matches include several major facilitator superfamily (MFS) transporters and sulphur transferases, indicating that this cut-off would not be feasible.
Indeed, there is no foolproof approach to making sure that a read comes from a functional resistance gene. Even if 100% identical to a resistance gene, the read only represents a part of the gene sequence, and the gene the read is derived from may, for example, be truncated and thus non-functional. However, as seen in the example with IMP, it is important that the cut-offs are not set too low to ensure that stringency is retained. Thus, requiring sequence identity of 80%-95% is probably warranted. Furthermore, the larger the datasets grow, the more computing resources will be required to process them. Read mapping of short read data from high-throughput sequencing allowing for a large number of mismatches is typically computationally much more expensive than searching for high-identity matches. Thus, the choice of cutoff value becomes a trade-off between speed, sensitivity and stringency. For example, employing a cut-off of two amino acid mismatches per read will correspond to a percentage identity of 90-94, depending on the read length. Many software tools exist to efficiently map reads to protein reference databases, employing different computational approaches, including Vmatch, 46 Usearch 47 and Diamond. 48 
Databases for resistance genes
The choice of reference databases also has important implications for the quality of the information derived. Since annotation Review JAC based on bioinformatic analysis of sequence similarity will never be more accurate than that of the reference sequences, selecting a reference database with high-quality annotation is crucial. 41 Simply put, if the database only contains resistance genes against b-lactams, you will likely grossly underestimate the number of resistance genes present. On the other hand, if the database contains genes incorrectly predicted to have resistance functions, the abundance and diversity of resistance genes in the sample will be overestimated. A number of databases containing antibiotic resistance gene information exist. An often-used resource, particularly in the early papers using metagenomics to investigate antibiotic resistance, is the Antibiotic Resistance Genes Database (ARDB), established in 2008. 49 However, a few problems exist with ARDB. Most prominently, its last update was in July 2009, meaning that any resistance gene discovered after that date is not included in the database (this includes, for example, the clinically very important carbapenemase NDM-1 50 and the newly discovered mcr-1 51 ). In addition, ARDB does not make any distinction between resistance genes with a confirmed resistance function and those predicted to confer resistance based on homology. Thus, the database may very well contain sequences that in fact are not functional resistance genes. ARDB has subsequently been structured by resistance types and has had some obviously erroneous sequences removed, 17 and this version of the database remains in use. 52 However, the basic problems of the database being outdated and that the majority of sequences do not have their functionality demonstrated prevail also in this version. The developers of ARDB instead recommend the use of the Comprehensive Antibiotic Resistance Database (CARD). 53 This database is still in active curation and is possibly the most comprehensive resource for antibiotic resistance gene information available. However, although CARD is based on thorough curation, it does not clearly separate experimentally verified and predicted entries. Furthermore, it is unclear whether the genes in the database have been found on MGEs or have been detected only on chromosomes. That said, the use of a single reference sequence for every resistance gene in CARD increases the likelihood that each sequence has been confirmed to confer resistance in at least some species. Similar problems also haunt the ARG-ANNOT database, 54 although to a much larger extent. The ARG-ANNOT database employs what they refer to as 'relaxed search criteria' to identify resistance genes, which in reality means that the database contains a multitude of sequences with poor annotation information, and that many entries are unlikely to be functional resistance genes. This limits the value of ARG-ANNOT for identifying true resistance genes. A more stringent approach to this has been taken by the ResFinder 55 and Resqu 43 databases. Both these databases only contain sequences of acquired antibiotic resistance genes present on MGEs. However, a drawback associated with Resqu is that it has not been updated since 2013, while ResFinder remains actively curated.
How the database content affects results
Depending on the database used, reported resistance gene abundances may differ, despite the fact that the same bioinformatics protocols are applied. For example, ARDB, CARD and Resqu report radically different numbers of resistance genes in the human gut and sediment from a Swedish lake ( Figure 2 ; data from ). Resqu consistently reports the lowest numbers, likely since it only contains resistance genes with a verified resistance function that have been shown to be present on MGEs and thus excludes many generic efflux pumps that may confer low-level antibiotic resistance. From a risk perspective, mobile resistance genes are probably the most relevant to detect and quantify. 8, 10 Furthermore, many multidrug efflux pumps are relatively well conserved between variants with and without capacity to export antibiotics. 8 Using the full CARD database (2015 version) consistently reports resistance gene counts two to three times higher than ARDB. In a newer version of CARD, 53 chromosomal genes where point mutations provide resistance have been removed, and this version generates roughly the same results as ARDB (although not for the lake sediments). Genes containing such point mutations may indeed provide resistance, but are rarely transferable between bacteria and are-importantly-very similar to the susceptible variants of the target genes. The latter means that even reads stemming from susceptible ('wild-type') bacteria in a metagenome would map to these 'resistance genes', particularly if, for example, a 90% identity threshold were used. Diluting the database with such genes means that the total resistance gene content will undoubtedly be overestimated, as many of these target genes are ubiquitously occurring essential genes, highly conserved between bacterial species. For example, the rpoB gene (the target gene of rifampicin; mutated variants are present in the full CARD database) is present in a single copy in most bacterial species 57 and has thus been proposed as a possible per-genome normalization gene for metagenomics. 58 The presence of around one such 'resistance gene' per 16S rRNA in the Swedish lake sediment, as reported when using the full 2015 version of CARD (Figure 2 ), therefore seems reasonable. However, the vast majority of the reads associated with these 'resistance genes' actually derive from antibiotic-susceptible variants of essential target genes.
It is important to realize that this is not a problem related to the CARD database per se. The database web site clearly states that target genes are present among its sequences, and also provides a separate dataset with the target genes removed for use in metagenomic studies. Recently, CARD was also updated to fully separate target sequences and functional resistance genes in different files. 53 Still, if care is not taken in examining the content of the database used, this may lead to partially misleading conclusions, which may explain the surprising results of some studies. 59 A similar problem is the use of general annotation pipelines, such as the commonly used MG-RAST, 60 that are not curated with regard to antibiotic resistance. The use of MG-RAST to annotate resistance genes has led to some peculiar reports suggesting that almost 1 in 25 genes found in human faeces would confer antibiotic resistance. 61 The non-stringent identity cut-offs used by default in MG-RAST are likely to be a major cause of these results. Similar use of low identity thresholds in other studies has led to unexpectedly high estimates of resistance gene abundances in other human faeces samples. 62 This emphasizes the importance of accounting for technical factors that could explain unexpected results in metagenomic studies. Overall, there is a clear need for improved stringency with regard to database usage and parameter choices in metagenomics studies aiming to quantify resistance gene abundances.
Unsolved statistical problems for metagenomics
Once gene counts have been established, the next aim is usually to identify differences in resistance gene abundances between samples. Although this sounds straightforward, a number of technical obstacles remain. 28 The most fundamental problem Review JAC affecting the statistics of metagenomic data is that the data are high dimensional in the sense that there are generally many more observed genes than biological replicates. Furthermore, the variation between samples in the same group can be fairly large, meaning that higher numbers of replicates are required to detect statistically significant differences. 63 However, because sequencing is relatively expensive, a trade-off exists between obtaining sufficient sequencing depth for quantification of genes in each individual sample and the number of replicate samples that can be sequenced. Finally, since metagenomics generates counts, the resulting data are discrete, and many existing statistical tests assume continuous, normally distributed data. The last few years have seen tremendous development of statistical methods for metagenomic analysis, 64 somewhat reminiscent of the early advances in methods of microarray analysis. 65 However, many of these methods provide a descriptive picture of the studied community rather than highlighting statistically significant differences. 66 Interestingly, it took 10 years of microarray usage for statistical methods to catch up and become standardized, 67 and it is reasonable to assume that shotgun metagenomics faces a similar development towards robust standardization within the next few years.
Normalization of data to make samples comparable
Another problem with metagenomic sequence data is that the generated libraries may be of vastly different size, which influences the number of counts from different samples. Furthermore, the composition of the samples may be different, and technical factors can bias the sample processing. To make libraries from different samples comparable, normalization is applied. However, depending on the research question, different means of normalization can be appropriate. If one is merely interested in compensating for the different size of the sequence libraries, it would be sufficient to simply divide each count by the total number of reads of the corresponding library, generating, for example, a count-per-million value. However, when investigating antibiotic resistance it is often more relevant to determine the counts relative to the bacterial fraction of the sample (trying to exclude contributions from eukaryotes and viruses, for example). For this purpose, a bacterial marker gene is often used for normalization, most commonly the small subunit 16S rRNA, yielding gene counts per 16S rRNA. However, although the rRNA genes are well studied and often applied for normalization purposes, they can occur in multiple copies within the same genome, 68, 69 and thus other, single-copy bacterial marker genes have been suggested for normalization, 70, 71 such as the ribosomal protein rpoB gene. 57, 58 That said, since these normalization methods have not yet gained traction, and because of the legacy of qPCR studies, the 16S rRNA remains the most common normalization gene for studies of bacterial communities. One can imagine other relevant normalization strategies, such as comparing each gene count with the total content of resistance genes. Importantly, the choice of normalization method should be based upon the questions asked, and how these questions are best answered. It is also important to consider whether there are variations between samples that will not be compensated for under the normalization method chosen. Such variation may occur, for example, because of differing 16S rRNA copy numbers, or because not all variants of the marker gene of choice are detected by the methods used, which is a common problem, particularly when read lengths are short. 72 There are also completely different approaches to normalization used in RNAseq, based on minimizing the overall fold change between experiments, thereby attempting to reduce technical noise. 73 Similar thoughts have been carried over into recent metagenomic analysis packages, 74 although the task of identifying a subset of genes that can be assumed to be stable between samples is not as straightforward in data from communities comprising mixtures of species.
An additional factor that also may influence gene abundance estimates based on reads mapped to a reference database is the length of the reference genes. If this is not compensated for, longer genes may recruit more reads simply by chance. It is not necessary to compensate for this effect when data are analysed directly between samples. However, when abundances are compared between genes, the length needs to be taken into account to avoid potientially biased results. This type of normalization makes sense, but whether or not it is meaningful to compensate for it in real situations is debated. 75, 76 Some authors have suggested that compensating for gene lengths may even be detrimental to differential analyses of RNAseq data, 77 although whether the same argument is valid also for metagenomic data is unclear.
Data transformation approaches
Currently, the statistics for handling metagenomic count data are centred on three fundamentally different approaches: standard tests on transformed counts; tests assuming distributions that account for the features of count data; and non-parametric tests. Data transformations are often used to change the distribution of the data so that it better fits the normal assumptions of standard tests, such as t-tests and analysis of variance. For count data, the variance is always dependent on the mean, and proper data transformations remove this relationship. Such variance-stabilizing transforms include the square-root transform and various logarithm transforms. Note that logarithm transforms 'penalize' very large values harder than the square-root transform, and thus analysis of logarithm-transformed data is less influenced by the most abundant genes. Transformation methods allow the use of standard microarray analysis tools on count data, as implemented in, e.g. the Voom package, which estimates and weights the meanvariance relationships of each observation and subsequently analyses the transformed counts using Limma. 78, 79 One problem that becomes apparent when applying a logarithm transform to metagenomic count data is the large number of zeros present. Zeros lead to two problems. The first is practical-zeros cannot be logarithm transformed-and the second is that a zero can represent either that a gene is not present at all, or that it is so rare that the sequencing depth was not sufficient to detect it. The transformation problem can be solved by adding a pseudocount to all observations in the dataset, usually simply a count of 1. However, the pseudocounts may influence effect sizes (and thus statistical significances), particularly when overall gene counts are low, which has led some authors to advise against the use of transformation methods for count data in these cases. 80 The second problem associated with zeros is harder to deal with, and is particularly troublesome when estimating the richness and diversity of taxa or genes, a problem we will return to later. Efforts to handle zero inflation have been made in, for example, the metagenomeSeq Review package, which uses a zero-inflated Gaussian model to correct for undersampling-related bias. 81 
Non-parametric and count-adapted tests
As an alternative to data transformation, statistical tests that do not make such specific assumptions on the distribution of the data can be used. These are referred to as non-parametric tests, 82 and include, for example, tests based on the ranks of the observation rather than their actual values. These methods -for better and worse -do not depend on distributional assumptions and are therefore more robust to outliers in the data. Other non-parametric tests include permutation tests that resample the data instead of assuming that they follow any particular distribution. [83] [84] [85] Finally, there are also statistical tests designed to better handle count data, usually based on assumptions of Poisson or negative binomial distributed data, such as ShotgunFunctionalizeR, 86 which allows fitting of generalized linear models to metagenomic count data. Such models are also implemented in the RNAseq analysis packages edgeR 87 and DESeq, 88 which couple the variance and mean either naively (edgeR) or by determining the optimal coupling for each individual gene (DESeq). Both these tools are developed for RNAseq data, and although this technique generates similar count data, their assumptions may not be entirely valid for metagenomic analysis. A recent evaluation of different statistical approaches to the identification of significantly differing genes between metagenomes concluded that the number of replicates, the effect sizes and the gene abundances greatly affected the outcomes of each method, and that no single method is suitable for all metagenomic datasets and questions. 64 That said, the methods based on Poisson or negative binomial distributions used for RNAseq overall performed better, particularly with small group sizes, with DESeq and overdispersed Poisson linear models coming out on top. Surprisingly, ordinary square-root-transformed t-tests performed relatively robustly also at small group sizes. However, the evaluation also showed that several methods (non-transformed t-tests, Fisher's exact test and the binomial test) perform poorly and should be avoided. Furthermore, non-parametric methods also perform below par and should in most cases be replaced by methods based on transformation or appropriate modelling of counts.
Correction for multiple testing
Regardless of the method that is used to determine which genes are significantly enriched in a group of samples, one P value will be obtained for each gene tested. This means that, with a large reference database, hundreds or thousands of tests will be performed. Since the P value represents the probability of obtaining a particular result by chance, under the null hypothesis given certain model assumptions, 89 performing multiple tests will increase the probability of obtaining false-positive observations tremendously. 90 Therefore, large experiments with many measurements, such as using metagenomics to detect resistance genes, require some form of correction for multiple testing. One way of doing this is to simply multiply each P value by the number of tests performed (i.e. the number of genes investigated), referred to as the Bonferroni correction. 91, 92 However, in many explorative studies the Bonferroni correction is regarded as too conservative, and therefore more relaxed approaches, such as the Benjamini-Hochberg false discovery rate, are commonly used in large-scale experiments to control the number of false-positive observations. 93 
Measuring abundance and diversity of resistance genes
Not only the abundance of resistance genes in certain settings may be of importance for determining risks, but also the diversity of such genes found. However, it is debated how to best establish the diversity of resistance genes, for example whether or not the relative abundances of different genes should be taken into account. Similar difficulties with estimating species richness in different communities have haunted ecology for more than half a century. 94 A plethora of diversity indices designed for community ecology exist and are currently in use, each with its own advantages and shortcomings. The most basic such measurement would be to simply count the number of different resistance gene types encountered, establishing what is called the richness of the sample. This, however, is not without problems. 95 First of all, the richness is intimately connected with sampling effort (in the metagenomics case the size of the sequencing library). One could account for this by normalizing the abundances of each gene in all samples to the size of each sample, thereby making them comparable, and then only count entries with a normalized abundance corresponding to finding at least one copy of the gene in the smallest sample. However, while this reduces the dependency on library size, it instead introduces a bias towards the most abundant entities. For this reason, rarefaction methods, in which the number of different resistance gene types encountered is plotted against the sampling effort required to detect them, have instead been suggested to deal with this problem in community ecology. 96, 97 Furthermore, the studied sample of resistance genes only comprises a subset of the total resistance gene types likely to be present in a community. Thus, the true richness of the sample is unknown, and information on the abundances associated with low-abundance genes is either poorly estimated or lacking. This means that it might be informative to account for the unseen resistance genes in some way. Measures for extrapolating richness could be borrowed from ecology, for example the Chao1 98 and ACE 99 estimators. In addition, resampling methods have been suggested for estimating the true richness of samples. 100 However, these estimators have been shown to fluctuate substantially with changing sample size. 101 As ecologists and statisticians still struggle with the problem of estimating the number of rare species in a community, we can conclude that accounting for these is hard, and that for the time being we are probably best off comparing the richness of detected resistance genes in different samples and hoping that these numbers reflect the true richness reasonably well. In addition, the methods for finding resistance genes using shotgun metagenomics only allow detection of known genes present in a reference database. The yet undiscovered resistance genes, of which there seem to be a multitude both in the environment and in the human microbiome, 2,102-107 and which avoid detection regardless of being abundant or rare, are incredibly hard to account for using richness estimators. Once again, one could assume that a large diversity of known resistance genes implies a broad range of unknown resistance factors as well, but to what degree this is true remains unknown.
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What are the benefits of assembling metagenomes?
Depending on where an antibiotic resistance gene is located, its ability to confer resistance, as well as its potential to spread to other bacteria, varies considerably. 8, 10, 108 A central limitation of using short-read metagenomic data to study antibiotic resistance is thus that it is not possible to associate a read mapped to an identified resistance gene to a specific species or strain with certainty, hampering the evaluation of risks associated with resistance gene findings. In addition, different promoter regions may enhance or reduce the expression of a gene, and interactions with other gene products may influence the resistance function of the gene. Furthermore, a gene that is present on a plasmid or other MGE is vastly more likely to spread between bacteria than one firmly located on the bacterial chromosome. 8, 109 Also, the compatibility of a mobile resistance gene with its host influences whether the gene encodes an efficient resistance mechanism in that specific context. Finally, genes mobilized by integrases or transposases may have modified 3 0 and/or 5 0 ends, which may also alter their expression in the new context. The latter is thought to have contributed to the efficiency of the NDM-1 carbapenemase gene in a variety of hosts. 110, 111 Because of the complex interplay between the host, its resistance genes and their genetic environment, it is important to consider the genetic context around resistance genes, as well as the taxonomy of their carriers. To fully understand the genetic context of resistance genes, functional selection of resistant strains or resistance plasmids followed by analysis of their complete sequences is in principle required. [112] [113] [114] [115] [116] This is, however, a rather labour-intensive approach, and it is also restricted to isolates that can be cultured and/or plasmids that can be captured by culturable bacteria. Another approach to gaining insight into the contexts of resistance genes is through the use of metagenomic shotgun sequencing followed by computational assembly of the reads. 16, 52 While this method is limited to resistance regions abundant in the sample, due to the requirement of large sequencing depth, it circumvents the need for culture and phenotypic resistance selection.
The current state of assemblers for metagenomic sequence data Early metagenomics projects, which generated longer and fewer reads, generally utilized the same assemblers as genome projects, such as the Celera assembler, 117 Newbler 118 or MIRA. 119 The assemblers used on long-read data are most often based on the overlap-layout-consensus algorithm, 120 which works well on smaller datasets, but quickly becomes vastly time-and memoryconsuming, as its complexity scales roughly quadratically with the number of reads due to the all-to-all comparisons of reads required. 121, 122 For the massive amount of short reads generated by, e.g. the Illumina platform, such algorithms are unsuitable because of the dramatically increased complexity. The first widely used assemblers for short-read data-e.g. SSAKE 123 -solved this by greedy approaches, which are less computationally expensive, but produce sub-optimal solutions to the assembly problem. 122 Instead, methods that reduce the complexity of the assembly graph by converting it into a de Bruijn graph 124, 125 quickly gained traction and remain the most used assembly methods for Illumina data. The de Bruijn graph is less complex to build and traverse than the overlap-layout-consensus graph, making the assembly problem easier to solve. 126 This has resulted in a plethora of assembly algorithms based on de Bruijn graphs, of which some popular examples are Velvet, 127 ABySS 128 and SOAPdenovo. 129 With increasing popularity of metagenomics, specialized software for metagenomic de novo assembly has also been developed. These programs are often modified versions of genomic assemblers, such as MetaVelvet, 130 Meta-IDBA, 131 metaSPAdes 132 and Ray Meta. 133 Although these adaptions in theory can improve assembly quality, the discernible difference between assemblies produced by, e.g. Velvet and MetaVelvet is minute, 134 which is also consistent with our own observations (J. Bengtsson-Palme, unpublished data). Benchmarking of different assemblers on data where the true result is known has shown that the N50 metric, which is often used to assess assembly quality, is generally useless since an assembler that merges too many reads together will get high N50 values (generally interpreted as good), but does so at the cost of generating chimeric contigs. 135, 136 This problem may be relatively minor for single genome assembly, since the possibilities for manual inspection and correction are larger. However, for metagenomic samples where many species are mixed, assessing which contigs may be chimeric is almost impossible, which makes the numbers of errors a central metric in selecting an assembler software. In this context, it is worrying to note that particularly SOAPdenovo, but also Velvet, produce relatively high numbers of errors compared with other assemblers, 135 such as ABySS and ALLPATHS-LG. 137 However, ALLPATHS-LG requires a very specific set of sequence libraries to operate, making it unsuitable as a general-purpose assembly tool. Furthermore, other comparisons indicate that ABySS and Velvet perform similarly (and produce comparatively few errors) on short-read data from bacterial genomes. 138 Aside from avoiding assembly errors, another important consideration as metagenomic datasets continue to grow is the issue of scalability. An efficient assembler must be able not only to deliver mostly correct contigs, but also to do so within a reasonable timeframe and within attainable memory limits. Even though metagenomic assembly generally is carried out on large computer clusters with hundreds of gigabytes of RAM, assembly of some metagenomic datasets is still not feasible with current methods. 139, 140 This leads to compromises between the most accurate and most efficient assembly algorithms. One key parameter of large-scale assembly is that the software should be scalable across multiple processor cores and nodes (individual machines) in a computer cluster. Two assemblers have struck a reasonable balance between accuracy and scalability for metagenomic assembly: ABySS and Ray. Both are highly scalable, while still producing results comparable to those of Velvet. 56, 138 However, for really large metagenomes neither of these assemblers is sufficiently memory efficient, which has spurred the development of alternative assembly strategies. For example, reads can be binned based on k-mer content prior to assembly, reducing the need to assemble all the reads at once. 141 Furthermore, reads from low-coverage regions can be filtered out prior to assembly, 142, 143 or reads from high-coverage regions can be set aside, a strategy referred to as digital normalization. 140 Finally, merging of sub-samples of reads Review assembled individually has been proposed as a possible, albeit sub-optimal, assembly strategy. 144 A completely different approach to metagenomic assembly is to target only regions of interest in the metagenome, which also reduces the complexity of assembly. Such approaches have been implemented in assemblers such as TriMetAss, 16 and the SAT-Assembler.
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Assembly of genes existing in multiple genomic contexts
The greatest obstacle to enabling the assessment of the context of mobile resistance genes identified in metagenomic data is the nature of the resistance genes themselves. We are often interested in investigating whether a resistance gene is present on an MGE or not, as this property is strongly related to the relative risk associated with the gene. 8, 10 However, resistance genes present on MGEs are often better conserved between species (since they can be transferred directly) than chromosomal resistance genes. In addition, if they are mobilized in integrative elements they can exist in multiple similar, but not identical, genetic contexts. 16, 146, 147 This presents a problem for assembly software working with short reads. Many times, there can be multiple possible branches out from a highly conserved part of a resistance gene or resistance gene cassette ( Figure S1a , available as Supplementary data at JAC Online). Almost all assembler software handles this by splitting the contigs at the branching points, although some programs use coverage information or other external data (such as read-pair information) to avoid unnecessary splits and handle splits more intelligently. Regardless, the result is a fragmented assembly that does not contain much information about the genetic context of the resistance gene of interest. In the example presented in Figure S1 (a), no contextual information is retrieved for resistance gene A, since it ends up on a single contig without any flanking regions. This not only obscures the information about whether a resistance gene is transferable between bacteria, but also severely limits our ability to detect resistance genes that are co-localized. In addition, closely related resistance genes are often not identical across their entire length, but rather contain identical regions. In these cases, the individual resistance genes may also be split up on multiple shorter contigs, further complicating the assembly ( Figure S1b ).
The problems related to multiple contexts usually get worse the more common a resistance gene is, since common resistance genes are more likely to be detected in multiple contexts. In addition to these examples where true biological variation causes assembly problems, sequencing errors may also break up the assembly in a fashion similar to that shown in Figure S1 (b), although assemblers are generally better at handling such problems than true biological variation. Similarly to resistance genes existing in multiple contexts, integrases and transposases are prone to the same types of problems, and break assemblies up in an analogous 
Clinical resistome analysis using metagenomics
A variety of studies have investigated the abundance and diversity of resistance genes in the human microbiome, revealing overall trends related to body compartments, 14 antibiotic usage, 13, 148 early development in infants 149 and travel. 56 These studies have together contributed a baseline knowledge of how the human resistome is composed and how it varies across different countries. As a broadencompassing research tool to characterize the overall resistance gene composition of the human microbiota, metagenomic sequencing has proved to provide reliable and reproducible results. However, implementation of metagenomic approaches for clinical purposes is Figure 4 . A suggested workflow for resistance gene analysis in metagenomes. Specific recommended tools and databases are indicated by white boxes, while conceptual approaches are given in black boxes. Methodological steps are marked in grey boxes.
Review not without problems. First of all, for most sample types from humans except faeces, the vast majority of the reads will be derived from the human genome, unless some depletion strategy for human material is employed. Furthermore, even in faeces it has been shown to be hard to detect clinically important pathogens and resistance genes that could be isolated through selective culturing. 56 That said, with appropriate purification protocols it is possible to reliably detect resistant pathogens in, for instance, urine samples using metagenomic sequencing. 150, 151 The use of sequencing technology for this purpose may not yet be sufficiently fast and reliable for clinical diagnostics, but is likely to mature in the very near future. 152, 153 It is at present unclear whether the benefits of shotgun metagenomics justify the costs of implementing it as a clinical diagnostic tool, 5 particularly as PCR and culture-based approaches remain vastly more sensitive. 56, 154 However, metagenomic approaches could be used in epidemiology to track transmission, although this would at present be a costly practice. That said, sequence data can be re-investigated when novel resistance factors are discovered, 155 which enables probing for whether a new resistance gene is already widely spread in the human microbiome.
The influence of environmental faecal contamination
Detecting relatively larger numbers of antibiotic resistance genes in a metagenome than expected in the studied environment is often interpreted as a product of selection for antibiotic resistance. However, this is not necessarily the case. In the environment, the abundance of resistance genes often is tied to the relative proportion of faecal bacteria (Figure 3 ; data from Pal et al.
)
. This makes it difficult to infer whether an enrichment of resistance genes in a particular sample is due to selection for the resistance factor, or merely the by-product of contamination with faeces. Thus, the detection of resistance gene enrichments in certain sample types will not tell us much about selection unless placed in a taxonomic context, or if the levels detected are substantially above those in human faeces, which would also indicate selection for resistance. Because of the relationship between resistance genes and faecal pollution, it becomes important to estimate the proportion of bacteria derived from faeces in different environments. Since metagenomics enables detection of a wide diversity of taxa, the use of bacteria present in the human gut microbiome genome catalogue 156 has been proposed as a reference for tracking human faeces contamination in the environment. 157 Still, this approach will only provide an upper bound for the human-associated bacterial content, as many of the species present in this genome catalogue can exist also in the gut microbiome of other species, or in the external environment. Finding appropriate faecal markers remains an unsolved problem for using metagenomics in environmental resistance gene research, and a perfect solution may not even exist.
Conclusions
As should be evident from this overview, a multitude of approaches exist for resistance gene quantification and investigation in metagenomes. While the choice of methods should ultimately be made with respect to the questions asked and the samples investigated, some methods are clearly better suited for resistance gene studies than others. A suggested workflow for resistance gene analysis with the currently best-suited tools is given in Figure 4 . We would like particularly to emphasize the importance of choosing appropriate normalization strategies, and sufficiently stringent sequence identity cut-offs to avoid over-classification of resistance genes. Furthermore, the choice of database is also of critical importance to avoid misleading conclusions. Finally, appropriate statistical methodologies for metagenomic analysis are just starting to emerge 64 and we would like to encourage the reader to stay updated on these to make the most possible use of their metagenomic sequencing data. Nevertheless, the need for proper replication of samples will not disappear simply through the introduction of more sophisticated statistical methods. Although still costly, metagenomic sequencing is on the verge of finding clinical use in specific diagnostic situations, such as in the rapid characterization of urine and blood samples. Most likely, progress in sequencing technology will facilitate this development by driving prices down further, but will also yield longer reads and reads with lower error rates. This would be beneficial to gain substantial insights into the genetic contexts of resistance genes, which is fundamental to the differentiation of risks associated with resistance gene findings in different cohorts and environments. 
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